Abstract:Background Lupus nephritis (LN) is one of the most serious manifestations of systemic lupus erythematosus (SLE). Overactivation of type I interferon (IFN) signaling pathway is associated with LN pathogenesis, since overexpression of IFN stimulated genes (ISGs) has been found in the kidney of LN and deficiency of IFN receptor alleviates nephritis in lupus prone mice. Abnormal expression of microRNAs in renal tissues is linked to the pathogenesis of LN. However, the functions of these microRNAs and mechanisms for them to participate in the development of LN are largely unknown. In this study, we aimed to investigate the role of LN-associated renal microRNAs in the overactivation of IFN signaling pathway in the kidney of LN. Methods microRNA expression was measured by Taqman assay. Interferon-stimulated response element (ISRE)-luciferase reporter assay and western blotting were used to investigate the function of candidate microRNAs in IFN signaling pathway. mRNA expression was measured by SYBR green assay. Gene expression profile was done by microarray. Agomir and antagomir (chemical modified microRNA mimics and inhibitors) of the candidate microRNA was used to perform gain and loss of function experiments. Pristane induced lupus mouse model and NZB/NZW F1 mice were used to investigate the in vivo function of the candidate microRNA. Results Among revolutionary conserved differentially expressed renal microRNAs in LN, miR-127–3 p, which was reduced in the kidney biopsies of LN patients, inhibited IFN induced ISRE mediated expression of luciferase reporter gene, as well as the phosphorylation of STAT1 and STAT2. By microarray, we revealed that most of the ISGs were inhibited by miR-127–3 p in IFN stimulated Hela cells. Consistently, loss of function of miR-127–3 p augmented IFN response in human primary renal mesangial cells, with enhanced ISRE mediated expression of reporter gene, phosphorylation of STAT2 and ISGs expression. Further, we identified JAK1, the upstream tyrosine kinase of STAT1 and STAT2, as a novel target of miR-127–3 p. In vivo administration of miR-127–3 p agomir reduced ISGs expression and alleviated pulmonary hemorrhage induced by pristane in B6 mice and proteinuria in NZB/NZW F1 mice. Conclusions Our study shows miR-127–3 p can inhibit IFN signaling by targeting JAK1. Decreased expression of miR-127–3 p in the kidney contributes to the overactivated IFN response in LN. Subsequent mouse model studies indicate the therapeutic potential of miR-127–3 p in treating lupus associated organ damage. Funding Source(s): This work was supported by the National Basic Research Program of China (973 program) grant 2014CB541902 and the National Natural Science Foundation of China (No.81401331).

Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice

Increased Interleukin-22 Levels in Lupus Nephritis and Its Associated with Disease Severity: a Study in Both Patients and Lupus-Like Mice Model.

Lipocalin-2 Exacerbates Lupus Nephritis by Promoting Th1 Cell Differentiation

The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.

Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow–Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice

Increased Urinary Interleukin 22 Binding Protein Levels Correlate with Lupus Nephritis Activity

Group 3 Innate Lymphoid Cells Exacerbate Lupus Nephritis by Promoting B Cell Activation in Kidney Ectopic Lymphoid Structures

Elevated Interleukin-18 and Skewed Th1:Th2 Immune Response in Lupus Nephritis

Novel Mitophagy Inducer Alleviates Lupus Nephritis by Reducing Myeloid Cell Activation and Autoantigen Presentation.

MiR-146a Relieves Kidney Injury in Mice with Systemic Lupus Erythematosus Through Regulating NF-κB Pathway.

Honokiol Suppresses the Aberrant Interactions Between Renal Resident Macrophages and Tubular Epithelial Cells in Lupus Nephritis Through the NLRP3/IL-33/ST2 Axis

177 Decreased expression of renal MiR-127–3p contributes to the overactivation of interferon signaling pathway in the kidney of lupus nephritis

CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I Signaling

Interleukin-17 Expression Positively Correlates with Disease Severity of Lupus Nephritis by Increasing Anti-Double-stranded DNA Antibody Production in a Lupus Model Induced by Activated Lymphocyte Derived DNA.

A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis.

JAK/STAT Signaling Controls the Fate of CD8+CD103+ Tissue-Resident Memory T Cell in Lupus Nephritis

STAT1 aggravates kidney injury by NOD-like receptor (NLRP3) signaling in MRL-lpr mice

238 Leukocyte immunoglobulin-like receptor A3 (LILRA3) promotes lupus-like disease in a murine lupus model

Podocyte Activation of Nlrp3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis

CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice

iTreg cells-secreted IL10 alleviates lupus nephritis through inactivating lncRNA HAR1A transcription to suppress SMARCD1-mediated iNOS activation